Abstract
Hypertrophic cardiomyopathy (HCM), the most common cause of sudden death in the young, is an autosomal dominant disease characterized by ventricular hypertrophy accompanied by myofibrillar disarrays1. Linkage studies and candidate-gene approaches have demonstrated that about half of the patients have mutations in one of six disease genes: cardiac (β-myosin heavy chain (cβMHQ2,3) cardiac troponin T (cThT)4,5, α-tropomyosin (αTM)5'6, cardiac myosin binding protein C (cMBP-C)7–9, ventricular myosin essential light chain (vMLC1)10 and ventricular myosin regulatory light chain (vMLC2)10 genes. Other disease genes remain unknown. Because all the known disease genes encode major contractile elements in cardiac muscle11, we have systematically characterized the cardiac sarcomere genes, including cardiac troponin I (cTnl), cardiac actin (cACT) and cardiac troponin C (cTnC)12 in 184 unrelated patients with HCM and found mutations in the cTnl gene in several patients13. Family studies showed that an Arg145Gly mutation was linked to HCM and a Lys206Gln mutation had occurred de novo, thus strongly suggesting that cTnl is the seventh HCM gene.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Maron, B.J., Bonow, R.O., Cannon, R.O., Leon, M.B. & Epstein, S.E. Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology, and therapy. N. Engl. J. Med. 316, 780–789 (1987).
Jarcho, J.A. et al. Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1. N. Engl. J. Med. 321, 1372–1378 (1989).
Geisterfer-Lowrance, A.A.T. et al. A molecular basis for familial hypertrophic cardiomyopathy: a β cardiac myosin heavy chain gene missense mutation. Cell 62, 999–1006 (1990).
Watkins, H. et al. A disease locus for familial hypertrophic cardiomyopathy maps to chromosome 1q3. Nature Genet. 3, 333–337 (1993).
Thierfelder, L. et al. α-Tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 77, 701–712 (1994).
Thierfelder, L. et al. A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2. Proc. Natl. Acad. Sd. USA 90, 6270–6274 (1993).
Carrier, L. et al. Mapping of a novel gene for familial hypertrophic cardiomyopathy to chromosome 11. Nature Genet 4, 311–313 (1993).
Watkins, H. et al. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nature Genet. 11, 434–437 (1995).
Bonne, G. et al. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nature Genet 11, 438–440 (1995).
Poetter, K. et al. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nature Genet. 13, 63–69 (1996).
Hamada, H., Petrino, M.G. & Kakunaga, T. Molecular structure and evolutionary origin of human cardiac muscle actin gene. Proc. Natl. Acad. Sci. USA 79, 5901–5905 (1992).
Schreier, T., Kedes, L. & Gahlmann, R., Cloning, structural analysis, and expression of the human slow twitch skeletal muscle/cardiac troponin C gene. J. Biol. Chem. 265, 21247–21253 (1990).
Bhavsar, P.K., Brand, N.J., Yacoub, M.H. & Barton, P.J.R. Isolation and characterization of the human cardiac troponin I gene (TNNI3). Genomics 35, 11–23 (1996).
Liew, C.C. et al. Complete sequence and organization of the human cardiac beta-myosin heavy chain gene. Nucl. Adds Res. 18, 3647–3651 (1990).
Fodor, W.L. Human ventricular/slow twitch myosin alkali light chain gene characterization, sequence, and chromosomal location. J. Biol. Chem. 264, 2143–2149 (1989).
Bermingham, N. et al. Mapping TNNC1, the gene that encodes cardiac troponin I in the human and mouse. Genomics 30, 620–622 (1995).
Ko, Y.L. et al. Mapping the locus for familial hypertrophic cardiomyopathy to chromosome 11 in a family with a case of apical hypertrophic cardiomyopathy of the Japanese type. Hum. Genet. 97, 457–461 (1996).
Schwarts, K., Carrier, L., Guicheney, P. & Komajda, M. Molecular basis of familial cardiomyopathy. Circulation 91, 532–540 (1995).
Watkins, H. et al. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N. Engl. J. Med. 332,, 1058–1064 (1995).
MacRae, C.A. et al. Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3. J. Clin. Invest. 96, 1216–1220 (1995).
Beall, C.J. & Fyrberg, E. Muscle abnormalities in Drosophila melanogaster heldup mutants are caused by missing or aberrant troponin-l isoforms. J. Cell Biol. 114, 941–951 (1991).
Farah, C.S. & Reinach, F.C. The troponin complex and regulation of muscle contraction. FASEB J. 9, 755–767 (1995).
Solaro, R.J. Troponin C—troponin I interactions and molecular signaling in cardiac myofilaments. Adv. Exp. Med. Biol. 382, 109–115 (1995).
Syska, H., Wilkinson, J.M., Grand, R.J.A. & Perry, S.V. The relationship between biological activity and primary structure of troponin I from white skeletal muscle of the rabbit. Biochem. J. 153, 375–387 (1976).
Talbot, J.A. & Hodges, R.S. Synthetic studies on the inhibitory region of rabbit skeletal troponin I. J. Biol. Chem. 256, 2798–2802 (1981).
Farah, C.S. et al. Structural and regulatory function of the NH2 and COOH'terminal regions of skeletal muscle troponin I. J. Biol. Chem. 269, 5230–5240 (1994).
Tao, T., Gowell, E., Strasburg, G.M., Gergely, J. & Leavis, P.C. Ca2+ dependence of the distance between Cys-98 of troponin C and Cys-133 of troponin I in the ternary complex: resonance energy transfer measurements. Biochemistry 28, 5902–5908 (1989).
Lin, D., Bobkova, A., Homsher, E. & Tobacman, L.S. Altered cardiac troponin T in vitro function in the presence of a mutation implicated in familial hypertrophic cardiomyopathy. J. Clin. Invest. 97, 2842–2848 (1996).
Nishi, H. et al. A myosin missense mutation, not a null allele, causes familial hypertrophic cardiomyopathy. Circulation 91, 2911–2915 (1995).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kimura, A., Harada, H., Park, JE. et al. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet 16, 379–382 (1997). https://doi.org/10.1038/ng0897-379
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng0897-379
This article is cited by
-
Identification of variants in genes associated with hypertrophic cardiomyopathy in Mexican patients
Molecular Genetics and Genomics (2023)
-
Mechanisms of Sarcomere Protein Mutation-Induced Cardiomyopathies
Current Cardiology Reports (2023)
-
Predictive genomic tools in disease stratification and targeted prevention: a recent update in personalized therapy advancements
EPMA Journal (2022)
-
Personalized medicine in cardiovascular disease: review of literature
Journal of Diabetes & Metabolic Disorders (2021)
-
Advantages and Perils of Clinical Whole-Exome and Whole-Genome Sequencing in Cardiomyopathy
Cardiovascular Drugs and Therapy (2020)